- Previous Close
618.00 - Open
612.05 - Bid 617.85 x --
- Ask 619.95 x --
- Day's Range
608.25 - 631.35 - 52 Week Range
527.00 - 1,174.85 - Volume
39,414 - Avg. Volume
40,992 - Market Cap (intraday)
94.518B - Beta (5Y Monthly) --
- PE Ratio (TTM)
33.44 - EPS (TTM)
18.46 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
840.00
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. It offers dosage forms, such as tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form fill seals, topical preparations, eye drops, dry powder injections, rotacaps and gummies, and others. The company operates as pharmaceutical contract development and manufacturing company. It also sells branded pharmaceutical formulations. The company was incorporated in 2004 and is based in Delhi, India.
www.akums.in7,388
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: AKUMS.BO
View MorePerformance Overview: AKUMS.BO
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AKUMS.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AKUMS.BO
View MoreValuation Measures
Market Cap
94.52B
Enterprise Value
91.58B
Trailing P/E
33.45
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.41
Price/Book (mrq)
3.34
Enterprise Value/Revenue
2.34
Enterprise Value/EBITDA
23.53
Financial Highlights
Profitability and Income Statement
Profit Margin
6.80%
Return on Assets (ttm)
5.01%
Return on Equity (ttm)
16.60%
Revenue (ttm)
40.83B
Net Income Avi to Common (ttm)
2.78B
Diluted EPS (ttm)
18.46
Balance Sheet and Cash Flow
Total Cash (mrq)
7.95B
Total Debt/Equity (mrq)
18.63%
Levered Free Cash Flow (ttm)
607.29M